| An Evaluation of a Antimicrobial Stewardship Recommendation Bundle for Staphylococcus Aureus Bloodstream Infections (NCT06211829) | Methodist Health System | 2022-05-18 |
| Study to Evaluate the PK of IV and PO Omadacycline in Children and Adolescents With Suspected or Confirmed Bacterial Infections (NCT05217537) | Paratek Pharmaceuticals Inc | 2022-04-06 |
| Phenotypic Profile and Molecular Mechanism of Resistance in Carbapenemase-producing Enterobacterales and Pseudomonas Aeruginosa Isolates From Brazilian Hospitals: Implications for the Introduction of IMIPENEM-RELEBACTAM (NCT05285046) | D'Or Institute for Research and Education | 2022-04-01 |
| Study of the Safety and Pharmacokinetics of KSP-1007 Alone and Coadministered With Meropenem in Healthy Subjects (NCT05226923) | Sumitovant Biopharma, Inc. | 2022-01-12 |
| Drug-Drug Interaction Study of IV QPX2014 Combined With QPX7728 in Healthy Adult Subjects (NCT05072444) | Qpex Biopharma, Inc. | 2021-11-15 |
| A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of BWC0977 in Healthy Volunteers (NCT05088421) | Bugworks Research Inc. | 2021-11-05 |
| Pharmacokinetics of Colistin in Critically-ill Patients With AKI Who Receive SLED (NCT05586438) | Mahidol University | 2021-10-18 |
| AI-Guided Proteomic Biomarker Panel for Differentiating Bacterial and Viral Infections in Acute Febrile Illness (NCT07205575) | Qilu Hospital of Shandong University | 2021-09-01 |
| SAD/MAD Safety and PK Study of QPX9003 (Novel Polymyxin) in Normal Healthy Volunteers (NCT04808414) | Qpex Biopharma, Inc. | 2021-06-03 |
| Use of Low-cost Molecular Diagnostic Techniques as a New Surveillance Model for Diseases Preventable by Vaccinations. (NCT06322277) | Meyer Children's Hospital IRCCS | 2021-05-04 |
| Evaluation of a mNGS Workflow for Infection Diagnosis Using Oxford Nanopore Sequencing. (NCT04864873) | Capital and Coast District Health board | 2021-05-01 |
| Phase 1 Oral QPX7831 SAD and MAD in Healthy Adults (NCT04578873) | Qpex Biopharma, Inc. | 2021-04-13 |
| Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i) (NCT04841369) | CanSino Biologics Inc. | 2021-04-13 |
| Frequence of Dressing Change and Bacterial Colonization in Pediatric Intensive Care Unit (NCT04806776) | Children's Hospital of Fudan University | 2021-04-07 |
| PredictEndTB Signature for Individualizing Treatment in Multidrug-Resistant Tuberculosis (NCT04783727) | Research Center Borstel | 2021-04-01 |
| Intrapulmonary Pharmacokinetics of XNW4107, Imipenem and Cilastatin in Healthy Subjects (NCT04802863) | Evopoint Biosciences Inc. | 2021-03-25 |
| To Evaluate the Pharmacokinetics of XNW4107 in Healthy Adult Young Females and in Healthy Adult Elderly Males and Females. (NCT04801043) | Evopoint Biosciences Inc. | 2021-03-02 |
| Pharmacokinetics of XNW4107 in Subjects With Various Degrees of Renal Function (NCT04787562) | Evopoint Biosciences Inc. | 2021-02-25 |
| The Role of Lactate in Viral and Bacterial Infection (NCT04777747) | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 2021-01-01 |
| P1 Single and Multiple Ascending Dose (SAD/MAD) Study of IV QPX7728 Alone and Combined With QPX2014 in NHV (NCT04380207) | Qpex Biopharma, Inc. | 2020-11-24 |
| Impact of a Carrier (Infection, Colonization) of Highly Bacteria Resistance on the Patient's Quality of Life Hospital Environment (NCT04226001) | Hospices Civils de Lyon | 2020-11-16 |
| Incidence of Colonization by Multidrug-resistant Organisms in Mechanically Ventilated Patients With Severe COVID-19 (NCT05293418) | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 2020-10-01 |
| Blood Volume Assessment in COVID-19 and Bacterial Sepsis (NCT04517695) | NYU Langone Health | 2020-08-01 |
| Study to Evaluate Safety, Tolerability, and Pharmacokinetics of XNW4107 Alone or in Combination With Imipenem/Cilastatin (NCT04482569) | Evopoint Biosciences Inc. | 2020-07-10 |
| Compliance With AntibIotic TherapY Guidelines in French PICUs (NCT04642560) | University Hospital, Toulouse | 2020-06-15 |
| Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (NCT04100772) | CanSino Biologics Inc. | 2020-05-18 |
| Host RNA Profiles to Detect Infections in Young Infants (NCT04823026) | Rigshospitalet, Denmark | 2020-05-15 |
| The Association of Gene Polymorphisms With Invasive Bacterial Infections in Neonates and Young Infants (NCT06985160) | Ege University | 2020-04-25 |
| Prospective Study on Febrile Batteries in Pediatric Oncohaematological Patients (SuBiTo) (NCT06419426) | Associazione Italiana Ematologia Oncologia Pediatrica | 2020-04-22 |
| Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q) (NCT03896685) | Médecins Sans Frontières, France | 2020-04-06 |
| Febrile Infants - Diagnostic Assessment and Outcome (NCT04196192) | Belfast Health and Social Care Trust | 2020-03-01 |
| [18F]Fluoropropyl-Trimethoprim ([18F]F-TMP) PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects (NCT04263792) | University of Pennsylvania | 2020-02-07 |
| Biofilm Modified Macrophage Phenotype and Function in Diabetic Wound Healing (NCT03271580) | Indiana University | 2020-02-01 |
| Pharmacokinetics of Teicoplanin in Intensive Care and Haematology Patients (NCT04096092) | Radboud University Medical Center | 2020-01-15 |
| LázBarát™ (FeverFriend™) Projekt: Attitude Toward Fever and Its Change in the Healthcare System (NCT04633603) | University of Pecs | 2020-01-15 |
| Developing a Risk Assessment System of Multidrug-resistant Organisms Infection (NCT04688216) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2020-01-01 |
| Nudging Effect of Timer on Surgical Rub (NCT04609384) | Sygehus Lillebaelt | 2020-01-01 |
| Antibiotic Profile of Pathogenic Bacteria Isolated in Public Hospitals in Northern Jordan (NCT05106803) | Yarmouk University | 2019-08-01 |
| Study to Optimize the Use of New Antibiotics (NCT03941951) | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2019-07-09 |
| Preventing Young Infant Infections Using Azithromycin in Labour (PreYIAL) Trial (NCT03925480) | Murdoch Childrens Research Institute | 2019-07-01 |
| A Single Ascending Dose Study of AV-006 in Healthy Subjects (NCT03931876) | Arixa Pharmaceuticals | 2019-06-24 |
| Phase 1 Study of Oral QPX2015 in Healthy Adult Subjects (NCT03939429) | Qpex Biopharma, Inc. | 2019-05-20 |
| Effectiveness of a Hydrophobic Dressing for Microorganisms' Colonization and Infection Control of Vascular Ulcers (NCT03667937) | University of Malaga | 2019-05-15 |
| Clinical Impact of 16S rDNA PCR (NCT03915275) | University Hospital, Strasbourg, France | 2019-05-01 |
| Therapeutic Drug Monitoring of Teicoplanin in Children (NCT03933748) | Shandong University | 2019-04-01 |
| Clinical Impact of Rapid AST Directly From Blood Cultures (NCT03992703) | Fondation Hôpital Saint-Joseph | 2019-04-01 |
| Infections Following NeuroSurgery (INS) (NCT03857295) | Neuromed IRCCS | 2019-03-11 |
| Pharmacokinetics of Piperacillin and Tazobactam in Critically Ill Patients (NCT03738683) | Radboud University Medical Center | 2019-02-01 |
| Nurse Promotion of IV to PO Antimicrobial Conversion (NCT03761043) | Kelowna General Hospital | 2019-01-08 |
| A Safety and PK Study of IV Eravacycline (NCT03696550) | Tetraphase Pharmaceuticals, Inc | 2018-12-20 |
| Xydalba Utilization Registry in Germany (NCT03696901) | Correvio International Sarl | 2018-11-21 |
| Bacterial Infections in Patients with Cirrhosis in Argentina: Clinical and Microbiological Characteristics (NCT03919032) | Hospital Italiano de Buenos Aires | 2018-10-16 |
| Serum Ceftazidime Concentrations in Hemodialysis Patients (NCT03634904) | Centre Hospitalier Universitaire de Charleroi | 2018-09-15 |
| Xydalba Utilization Registry in France (NCT03726216) | Correvio International Sarl | 2018-09-06 |
| PK/PD and Clinial Outcomes of Beta-lactams in ICU Patients (NCT03858387) | Prince of Songkla University | 2018-09-01 |
| Controlled Human Infection for Vaccination Against Streptococcus Pyogenes (NCT03361163) | Andrew Steer | 2018-07-10 |
| Study of the Involvement of IL-17 / IL-22 Pathway in Bacterial Exacerbations of COPD (NCT02655302) | University Hospital, Lille | 2018-07-04 |
| Influence of the Implant-prosthetic Connection in the Marginal Bone Loss and Bacterial Leakage (NCT04328051) | University of Barcelona | 2018-06-13 |
| A Single Ascending Dose Study of BTZ043 (NCT03590600) | Michael Hoelscher | 2018-06-07 |
| Risk-factors for Multidrug-resistant Bacteria Colonization Among Patients at High Risk of STIs (NCT03767374) | Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba | 2018-05-11 |
| A Phase 1 TP-271 Oral PK Multiple Ascending Dose Study (NCT03450187) | Tetraphase Pharmaceuticals, Inc | 2018-03-20 |
| Effect of Passive Ultrasonic Irrigation on Bacteria That Persist After Root Canal Preparation (NCT05100433) | University of Sao Paulo | 2018-03-05 |
| 11C-Trimethoprim PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects (NCT03424525) | University of Pennsylvania | 2018-02-01 |
| Direct Molecular Characterization of Bacteria From ICU and From the REHAB (NCT03475472) | University Hospital, Basel, Switzerland | 2018-02-01 |
| Interest of Eosinopenia to Predict In-hospital Mortality Among Elderly Patients (NCT04734431) | Centre d'Investigation Clinique et Technologique 805 | 2018-01-01 |
| VNRX-5133 Drug-Drug Interaction in Healthy Adult Volunteers (NCT03332732) | Venatorx Pharmaceuticals, Inc. | 2017-10-24 |
| OR PathTrac (Tracking Intra-operative Bacterial Transmission) (NCT03605498) | Sundara Reddy | 2017-09-05 |
| Efficacy and Safety of Colistin Based Antibiotic Therapy (NCT04764058) | Ain Shams University | 2017-09-01 |
| A Phase 1 Safety and PK Study of IV TP-271 (NCT03234738) | Tetraphase Pharmaceuticals, Inc | 2017-08-16 |
| Adjunctive Steps for Disinfection of Teeth With Primary Endodontic Infections (NCT03537664) | University of Sao Paulo | 2017-08-04 |
| Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) (NCT03233438) | Allergan | 2017-07-24 |
| Bacterial Infections in Cirrhotic Patients With Acute Severe Liver Injury (NCT03204591) | The Zhejiang Study Group for Organ Failure in Cirrhosis | 2017-07-20 |
| Pharmacokinetics of Flucloxacillin Given by Continuous or Intermittent Infusion to ICU Patients (NCT02993575) | Radboud University Medical Center | 2017-06-01 |
| Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA (NCT02814916) | AbbVie | 2017-03-30 |
| Study of Ceftazidime-Avibactam Blood Concentrations in Intensive Care Unit Patients With Renal Failure Requiring Continuous Dialysis (NCT03243864) | Temple University | 2017-03-13 |
| A Phase 1 TP-271 Oral PK Single Ascending Dose Study (NCT03024034) | Tetraphase Pharmaceuticals, Inc | 2017-03-02 |
| Pharmacokinetics of Ciprofloxacin in Critically Ill Patients (NCT03016845) | Radboud University Medical Center | 2017-01-01 |
| Pharmacokinetics of Ceftazidime-avibactam Among Critically-ill Patients Receiving CVVHDF (NCT04358991) | University of Pittsburgh | 2017-01-01 |
| Fosfomycin I.v. for Treatment of Severely Infected Patients (NCT02979951) | Infectopharm Arzneimittel GmbH | 2016-12-01 |
| Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics (NCT02527681) | Basilea Pharmaceutica | 2016-11-22 |
| VNRX-5133 SAD/MAD Safety and PK in Healthy Adult Volunteers (NCT02955459) | Venatorx Pharmaceuticals, Inc. | 2016-11-01 |
| Diagnostic Breath Analysis for Detection of Ventilator Acquired Pneumonia (VAP) (NCT03053258) | Landon Pediatric Foundation | 2016-10-01 |
| Microbiological Epidemiology in Patients Experiencing Microbiological or Clinical Failure Following Reimplantation After a 2-stage Exchange Strategy for Hip or Knee Prosthetic Joint Infection (NCT03627000) | Hospices Civils de Lyon | 2016-10-01 |
| Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI (NCT02877927) | Paratek Pharmaceuticals Inc | 2016-08-01 |
| The Search for Viral and Bacterial Etiology of Varicocele (NCT03079609) | Medical University of Warsaw | 2016-07-01 |
| Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections (NCT02687906) | Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC) | 2016-07-01 |
| Multi-Drug Resistant Organism Network (NCT03646227) | Duke University | 2016-06-16 |
| A Controlled, Blinded Study to Validate the Diagnostic Accuracy and Assess the Clinical Utility of a Host-response Based Diagnostic Tool for Distinguishing Between Bacterial and Viral Etiologies in Pediatric Patients Presenting to the ED With Suspicion of Acute Infection (NCT04254991) | MeMed Diagnostics Ltd. | 2016-05-30 |
| Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial Infection (NCT02688790) | AbbVie | 2016-04-01 |
| The Value of the Neutrophil to Lymphocyte Ratio in the Diagnosis of Bacterial Infections (NCT02848534) | Centre Hospitalier Universitaire, Amiens | 2016-02-06 |
| Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study. (NCT02852902) | Spanish Network for Research in Infectious Diseases | 2016-01-01 |
| Preauthorization Versus Prospective Audit in Antimicrobial Stewardship Program (NCT02837081) | Kaohsiung Veterans General Hospital. | 2015-12-01 |
| PK of Clindamycin and Trimethoprim-sulfamethoxazole in Infants and Children (NCT02475876) | Michael Cohen-Wolkowiez | 2015-11-01 |
| Characterization of Resistance Against Live-attenuated Diarrhoeagenic E. Coli (NCT02541695) | NIZO Food Research | 2015-09-01 |
| Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium+Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013) (NCT02452047) | Merck Sharp & Dohme LLC | 2015-08-21 |
| ANti-infective Stewardship Using the Wisca Tool in the Electronic Medical Record (NCT03397433) | Endeavor Health | 2015-06-15 |
| Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23) (NCT02378480) | Paratek Pharmaceuticals Inc | 2015-06-01 |
| Study of Debio 1450 for Bacterial Skin Infections (NCT02426918) | Debiopharm International SA | 2015-05-01 |
| MRX-I Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection (NCT02269319) | MicuRx | 2015-02-01 |
| MALDITOF Versus Routine Clinical Microbiology for Identifying Pathogens; a Randomized Diagnostic Trial (NCT02306330) | Oxford University Clinical Research Unit, Vietnam | 2014-12-01 |